Lenvatinib, Lenvatinib, KEYTRUDA 25 mg/mL concentrate for solution for infusion
MK-3475-B60
Phase 2 small_molecule active
Quick answer
Lenvatinib, Lenvatinib, KEYTRUDA 25 mg/mL concentrate for solution for infusion for Advanced unresectable classic Kaposi sarcoma relapsed and/or refractory to previous standard treatments. is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Advanced unresectable classic Kaposi sarcoma relapsed and/or refractory to previous standard treatments.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active